Kurt Hilzinger Joins Vesey Street Capital Partners as Vice Chairman

Vesey Street Capital Partners Welcomes Kurt Hilzinger

In a significant move to bolster its leadership, Vesey Street Capital Partners (VSCP), a prominent private equity firm focused on lower middle market healthcare services, has announced the appointment of Kurt Hilzinger as the Vice Chairman of its Strategic Advisory Board. This strategic addition is aimed at leveraging Hilzinger's extensive experience and insights to support VSCP's growth and operational excellence.

A Visionary Addition to the Team

Adam Feinstein, the Founder and Managing Partner at VSCP, expressed his enthusiasm regarding the announcement, stating, "We are honored to welcome Kurt Hilzinger, a luminary in both the healthcare and private equity industries, to our firm. Having known him for over three decades, I am confident that his operational insight will align perfectly with our hands-on investment approach. His expertise will be an invaluable resource for our management teams and partners as we continue our expansion."

This sentiment resonates greatly within VSCP, where a commitment to operational excellence is more than a strategy; it's a core principle. Hilzinger's appointment marks a noteworthy pivot towards integrating expertise from various sectors into the firm's broader strategy.

A Track Record of Success

Kurt Hilzinger's career boasts a remarkable journey characterized by high-stakes value creation. He was instrumental in the recapitalization and IPO of AmeriSource Health Corp., a milestone achievement that led to its historic merger with Bergen Brunswig Corp. This merger created AmerisourceBergen, which is now known as Cencora. Since 2014, Hilzinger has taken on the role of Chairman at Humana Inc., steering the company through transformative phases of growth and digital innovation.

Furthermore, his experience as an executive advisor at Court Square Capital Partners enriches his profile, where he developed a robust understanding of the private equity lifecycle and demonstrated an exceptional ability to navigate and identify successful investments in the pharmaceutical services sector.

Strengthening the Strategic Advisory Board

Dave King, Chairman of VSCP’s Strategic Advisory Board, shared his thoughts on Hilzinger's contribution: "Kurt's addition strengthens our board by enhancing our depth of experience in both payor services and the pharmaceutical supply chain. His perspectives, along with his extensive operational experience, will provide significant value across our portfolio companies."

The ability to leverage Hilzinger's insights is anticipated to further VSCP's mission to invest strategically and effectively within the healthcare landscape, emphasizing the importance of leadership with a well-rounded understanding of the market.

Future Prospects

Kurt Hilzinger himself expressed his eagerness to join VSCP, stating, "VSCP has distinguished itself through a disciplined, thesis-driven approach to the lower middle market—a segment where operational expertise drives outsized returns. After a career dedicated to scaling healthcare platforms and mastering supply chain complexities, I am excited to partner with the entire VSCP team. Together, we will identify untapped opportunities and catalyze growth across the firm's dynamic portfolio."

About Vesey Street Capital Partners

Vesey Street Capital Partners is a private equity firm that specializes in the buyout of lower middle-market healthcare services businesses. Catering to a diverse range of Limited Partners, including asset management firms, family offices, and pension funds, VSCP has successfully executed 47 transactions across thirteen platform businesses. To date, the firm has deployed over $1 billion in equity capital, reaffirming its status as a critical player within the healthcare investment space.

For more information, interested parties can visit Vesey Street Capital Partners' website.

For media inquiries, please contact Tiffany Laing at Vesey Street Capital Partners, located at 412 West 15th Street, 2nd Floor, New York, NY 10011, or reach out via email at [email protected] or phone at (646) 847-2474.